A Deep Dive into the Trial Results CagriSema, a novel combination therapy comprising cagrilintide and semaglutide, delivered an average weight…
Read More
Biological Pathway Linking Gut Immune Response to Brain-Mediated Appetite Loss Identified by UCSF Researchers
The profound loss of appetite that accompanies severe gastrointestinal distress is a universal human experience, yet the precise biological mechanisms…
Read More
Science News: A Century of Empowering Public Understanding of Science, Medicine, and Technology
Founded in 1921, Science News has carved an enduring niche as an independent, nonprofit beacon of accurate information, illuminating the…
Read More
Unlocking Deep Time: Ancient Regulatory DNA Rewrites Plant Evolution
Scientists have long been captivated by the vastness of deep space, a realm of cosmic wonders and astronomical mysteries. Yet,…
Read More
TWiV 1291: A foot in the door for cytomegalovirus
This week on "This Week in Virology" (TWiV), the podcast hosted by Vincent Racaniello, Alan Dove, Rich Condit, and Brianne…
Read More
Closing the Information Gap: ETH Zürich Team Integrates Function and Binding in One Drug Screening Assay
In a significant advancement poised to reshape the landscape of pharmaceutical development, a collaborative team from ETH Zürich and the…
Read More
Researchers at Chiba University Develop Viciazite Carbon Materials to Enable Low-Temperature Carbon Dioxide Capture and Reduce Industrial Emissions
The global effort to mitigate climate change has reached a critical juncture as atmospheric carbon dioxide (CO2) levels continue to…
Read More
The Fundamental Mechanics of Human Hair Growth Redefined by Groundbreaking Cellular Discovery
A revolutionary scientific breakthrough is poised to rewrite biology textbooks and reshape our understanding of a fundamental human characteristic: hair…
Read More
HKUMed Researchers Identify Piezo1 as Key Bone Exercise Sensor Opening New Frontiers for Osteoporosis Treatment
The LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has announced a landmark discovery in the field…
Read More
Novo Nordisk’s triple agonist delivers up to 19.7% average weight loss in Phase 2 trial
Novo Nordisk has announced significant positive results from a Phase 2 trial of its experimental triple agonist, UBT251, reporting a…
Read More
